Korones David N, Padowski Jeannie, Factor Brad A, Constine Louis S
University of Rochester School of Medicine and Dentistry, NY 14642, USA.
Neuro Oncol. 2003 Apr;5(2):116-20. doi: 10.1093/neuonc/5.2.116.
We questioned whether children with optic pathway tumors (OPTs) have an increased frequency of other CNS tumors on the basis of experience with a number of such children treated at our institution. The medical records of all patients with OPTs treated at Golisano Children's Hospital at Strong at the University of Rochester from 1957 to 2000 were reviewed to determine the incidence of additional CNS tumors in these children and whether the occurrence of these other CNS tumors is associated with any risk factors. Twenty-six children had OPTs. Twelve of the 26 children had biopsy-proved tumors; the remaining 14 were diagnosed on the basis of CT or MRI scans. Eight of the 26 patients (31%) had a total of 11 additional CNS tumors. (One child had 2 additional CNS neoplasms, and a second child had 3.) Nine were biopsy proved (3 glioblastoma, 3 anaplastic astrocytoma, 3 low-grade astrocytoma), and 2 were diagnosed by imaging studies alone (acoustic neuromas). Eight of the 11 tumors occurred at a median of 5 years (0.8-25 years) subsequent to the diagnosis of the OPTs; 3 were diagnosed simultaneously with the OPT. Of the 17 children with neurofibromatosis (NF) and OPTs, 8 (47%) had additional CNS tumors, while none of the 9 children (0%) without NF had other CNS tumors (P = 0.023). There was no association between radiation treatment of the primary OPT and subsequent development of other CNS tumors in the group as a whole, or when the analysis was confined to children with NF. Despite this lack of statistical association, all 7 CNS tumors that occurred following radiation arose in irradiated areas. The risk of simultaneous or subsequent CNS tumors in children with NF and OPTs is high. These children should be closely monitored for the simultaneous or subsequent occurrence of other CNS tumors.
基于在我们机构治疗的许多此类儿童的经验,我们质疑患有视路肿瘤(OPT)的儿童是否有更高频率的其他中枢神经系统肿瘤。回顾了1957年至2000年在罗切斯特大学斯特朗分校戈利萨诺儿童医院接受治疗的所有OPT患者的病历,以确定这些儿童中其他中枢神经系统肿瘤的发生率,以及这些其他中枢神经系统肿瘤的发生是否与任何风险因素相关。26名儿童患有OPT。26名儿童中有12名经活检证实患有肿瘤;其余14名根据CT或MRI扫描诊断。26名患者中有8名(31%)总共患有11种其他中枢神经系统肿瘤。(一名儿童有2种额外的中枢神经系统肿瘤,另一名儿童有3种。)9种经活检证实(3种胶质母细胞瘤、3种间变性星形细胞瘤、3种低级别星形细胞瘤),2种仅通过影像学研究诊断(听神经瘤)。11种肿瘤中有8种在OPT诊断后的中位时间为5年(0.8 - 25年)出现;3种与OPT同时诊断。17名患有神经纤维瘤病(NF)和OPT的儿童中,8名(47%)有其他中枢神经系统肿瘤,而9名没有NF的儿童中无一例(0%)有其他中枢神经系统肿瘤(P = 0.023)。在整个组中,原发性OPT的放射治疗与随后其他中枢神经系统肿瘤的发生之间没有关联,当分析仅限于患有NF的儿童时也是如此。尽管缺乏统计学关联,但放射治疗后出现的所有7种中枢神经系统肿瘤均出现在照射区域。患有NF和OPT的儿童同时或随后发生中枢神经系统肿瘤的风险很高。这些儿童应密切监测是否同时或随后发生其他中枢神经系统肿瘤。